Related Experiment Video
Updated: Jan 14, 2026
Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity
Published on: March 31, 2023
Clinical significance and expression of ALDH1 in triple-negative breast cancer
Yaoyao Yang1,2,3,4,5, Zhuoran Li1,2,3,4,5, Yangyang Zhu1,2,3,4,5
1Department of Central Laboratory, Binzhou People's Hospital, Binzhou, 256600, People's Republic of China.
Background:
Triple-negative breast cancer (TNBC) is aggressive and has limited therapeutic options due to the absence of targeted therapies, highlighting the urgent need for prognostic biomarkers linked to cancer stemness and chemoresistance. Aldehyde dehydrogenase 1 (ALDH1), a key regulator of stem cell properties, remains incompletely characterized in TNBC clinical cohorts.
Methods:
ALDH1 mRNA expression levels were analyzed using the GEO2R online database, and its prognostic significance was assessed via the Kaplan‒Meier plotter tool. Immunohistochemical (IHC) staining was performed on a tissue microarray comprising 96 TNBC samples and paired adjacent normal tissues from patients treated at Binzhou People's Hospital between 2016 and 2022. The associations between ALDH1 expression and clinicopathological parameters were evaluated using the chi-square test.
Results:
Bioinformatics analysis revealed significantly higher ALDH1 mRNA expression in TNBC tissues compared to adjacent benign tissues. Kaplan‒Meier survival analysis demonstrated that elevated ALDH1 mRNA expression was associated with poor prognosis in TNBC patients. IHC staining further confirmed elevated ALDH1 protein expression in TNBC tissues compared with normal adjacent tissues. However, there was no significant correlation between ALDH1 expression and conventional clinicopathological parameters, including age, menopausal status, tumor size, TNM stage, histological grade, histological subtype, axillary lymph node metastasis and the Ki-67 index (p > 0.05). High ALDH1 expression was significantly associated with poorer overall survival ( χ2 = 16.836, p < 0.001).
Conclusion:
Our data demonstrate that ALDH1 expression is not significantly associated with conventional clinicopathological parameters (such as age, TNM stage, or histological grade). Instead, it is associated with poorer survival on univariate analysis in TNBC patients. Its lack of association with clinicopathological factors suggests its potential utility as a supplementary prognostic indicator.
